Smooth has started to work on the following projects:

• Our company started to develop medical documentation for a bioequivalence clinical trial in a drug for infectious and inflammatory diseases, conducted by a leading Russian company.
• Smooth is developing medical documentation and EDC for an observational trial of a global company. Our team is also responsible for the training in EDC of the study team.
• Smooth prepares to launch a phase III clinical trial of a biopharmaceutical in osteoporosis.
• Our company launches a bioequivalence trial in arthritis for a global pharmaceutical company.
• Smooth is developing medical documentation for bioequivalence trial of global company.
• Our team is preparing to launch a phase III in schizophrenia for an Asian company. The trial will take place in Russian and Ukraine.

We reached important milestones in the following projects:

• Smooth clinical team has launched a phase II clinical trial in steatohepatitis for a Russian pharmaceutical company.
• Our clinical team opened enrollment in EMA controlled study in pediatrics.